Navigation Links
Most Asthmatics Don't Have Illness Under Control
Date:10/25/2007

d they would like to better control their asthma.
  • Most asthma patients (59 percent) try to avoid taking asthma medications whenever possible, which suggests that they are not properly controlling the disease.
  • One in three (33 percent) asthma patients used a rescue inhaler at least daily, and 73 percent have used a rescue inhaler at least once in the past month.

    • "Using a rescue medication regularly is a sign that asthma is not properly controlled, and you may be ailing from the disease unnecessarily," Dr. William E. Berger, of the division of allergy and immunology at the University of California, Irvine, said in a prepared statement. "According to NAEPP (National Asthma Education and Prevention Program) respiratory guidelines, asthma patients should ideally use their rescue inhaler twice a week or less."

    The survey also examined a number of specific groups of asthma patients and found:

    • Two-thirds (65 percent) of female asthma patients said the condition limits their usual activities or enjoyment of daily life to varying degrees, and 95 percent said they'd experienced at least one of the five common asthma symptoms in the past year.
    • Only 8 percent of Hispanic respondents said they'd been diagnosed with asthma, but 58 percent said they'd experienced asthma symptoms.
    • While 13 percent of black American respondents said they'd been diagnosed with asthma, 58 percent reported experiencing asthma symptoms.
    • Compared to the general sample population, black American respondents were less likely to know about specific asthma risk factors, such as respiratory infections (71 percent vs. 58 percent) and living in an inner city (68 percent vs. 55 percent).

    More information

    The American Academy of Family Physicians has more about asthma con
    '/>"/>

    Copyright©2007 ScoutNews,LLC.
    All rights reserved

    0

    GOOD

    Page: 1 2 3

    Related medicine news :

    1. What happens when Asthmatics consume Aspirin?
    2. Soluble IL-4 Receptor - A new boon for asthmatics
    3. Easing Fears Among Asthmatics
    4. Asthmatics at increased risk of lung cancer
    5. Asthmatics May Be At Risk for Lung Disease In The Future
    6. Biofeedback Found To Reduce Steroid Dependence In Asthmatics
    7. Reducing Corticosteriod Use In Asthmatics
    8. Vitamin C – Supplementation A Boon For Asthmatics
    9. Asthmatics need to be on guard for Major Diseases
    10. New lease of life for asthmatics by Accentia Biopharmaceuticals
    11. Asthmatics, it pays to quit smoking
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2009)... last few weeks there has been an increase of ... e cigarette opposition in an attempt to scare the ... tactics of these groups when the evidence clearly shows ... tobacco according to several studies, lab reports and opinions ... world. ,, Special interest groups appear to have ...
    (Date:12/17/2009)... Calif., Dec. 17 Abaxis, Inc. (Nasdaq: ... point-of-care blood analysis instruments and rapid tests for ... that it has entered the production animal diagnostics ... Influenza Antigen Test. This is a USDA-licensed test ... chickens, turkeys and ducks. The disposable, non-instrumented device, ...
    (Date:12/17/2009)... LONDON, December 17 Researchers from the ... Loughborough University in the UK are today,encouraging ... in the,New Year following concerning research* that shows ... together as a family (68%), with the,Portuguese being ... likely to,walk together. , ...
    (Date:12/17/2009)... functions were determining factors. StaffKnex, developers of web-based nurse ... selected by Lifespace Communities to deliver its software solution ... ... Cleveland, OH (PRWEB) December 17, ... nurse scheduling and employee communication software, recently announced it ...
    (Date:12/17/2009)... engines like Google Local and in front of their local customers ... Registration service offered by New Orleans based Webtyde Internet Marketing. ... ... In order to be competitive locally and nationally, businesses must have ... local map section in a major search engine, a business must ...
    Breaking Medicine News(10 mins):Health News:Special Interest Deceptions Continue to Rampant About Electronic Cigarettes 2Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 2Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 3Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 4Health News:The Family Walk - a Dying Tradition Around the World? 2Health News:Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications 2Health News:Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications 3Health News:New Orleans Based Internet Marketing Is Helping Small Businesses Get a Chance to Shine On the Web 2
    ... that evening administration of the central alpha(2)-agonists guanabenz ... the morning in hypertensive patients. The study was ... receive once-daily evening administration of guanabenz or clonidine ... of the two drugs in the morning and ...
    ... lifestyle with limiting TV time could prevent obesity and type ... watching results in a lower metabolic rate when compared to ... a car. Prolonged TV watching is also linked to obesity ... and hardly concentrate on reducing sedentary behaviours.// ...
    ... that treatment with adult stem cells has cured mice ... have recovered completely from paralysis of their back legs, ... with stem cells extracted from the brains of adult ... showed that the stem cells had migrated to and ...
    ... in Journal of the American College of Cardiology suggests ... profile for the heart when delivered through a patch ... the largest study of its kind, was cut short ... Replacement Therapy (a combination of estrogen and progestin) increased ...
    ... glucose levels are above normal. People with diabetes have ... into a sugar called glucose, which is carried by ... the hormone insulin, made in the pancreas, to help ... can prevent or delay complications by keeping blood glucose ...
    ... discuss with their physicians, can be an early warning ... disease, hypertension, diabetes, high cholesterol, obesity and smoking are ... estimated that Erectile dysfunction affects 40 million men, yet ... tell and doctors never ask.// ED is one symptom ...
    Other Medicine News:
    (Date:12/16/2009)... 16 RealMed has been ranked ... the 2009 Top 20 Best in ... report. RealMed is a dynamic revenue cycle ... processing between healthcare providers and all ... firm specializing in vendor performance measurement in ...
    (Date:12/16/2009)... to Millennium Research Group (MRG), the global authority ... in China supported rapid expansion of the Chinese ... to fuel growth in the coming years. ... Cardiology Devices 2010 report finds that initiatives ... Chinese drug-eluting stent market to reach a value ...
    (Date:12/16/2009)... -- Biovista Inc.,today announced that it was awarded ... the 2009 New England Venture Summit, held on ... cutting edge private companies,driving the future of innovation, ... other privately held companies that play a leading ... Clean-tech sectors. , "We ...
    Breaking Medicine Technology:RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 2Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 3Biovista Inc. Named Top Innovator in Life Sciences 2Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU 016 55596 1Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU 016 55596 2Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU 016 55596 3Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU 016 55596 4Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU 016 55596 5Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU 016 55596 6Fast Food Choices for iPhone 28TM 29 iPod 28R 29 Touch Users With Celiac Coeliac 26 Food Allergies 55593 1Fast Food Choices for iPhone 28TM 29 iPod 28R 29 Touch Users With Celiac Coeliac 26 Food Allergies 55593 2Haven Healthcare of Utah Receives Award for Quality Care Fourth Year in a Row 55588 1Haven Healthcare of Utah Receives Award for Quality Care Fourth Year in a Row 55588 2
    ... ... Annually, CAMBRIDGE, Mass., Aug. 2 ... trial of Mozobil(TM),(plerixafor) has successfully met its primary and secondary endpoints,demonstrating positive ... non-Hodgkin,s lymphoma. The combined strength of these two trials -- in ...
    ... KING OF PRUSSIA, Pa., Aug. 2 ... experiments with its small-molecule,MIF inhibitors showed oral ... the Company announced that it is advancing ... Macrophage Migration Inhibitory Factor, or MIF, is ...
    Other Medicine Technology:Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint 2Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint 3Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint 4Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint 5Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint 6Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint 7Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors 2
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: